3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Disease Models, Animal

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cooley, AJ; Culham, CA; Frisbie, DD; Grauer, GF; Johnson, HC; Longhofer, SL; Schultz, KT	1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Disease Models, Animal

Article	Year
Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis. American journal of veterinary research, 1991, Volume: 52, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Concanavalin A; Dinoprostone; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Kidney Glomerulus; Male; Pyridines; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase	1991

Article

Year

Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.

American journal of veterinary research, 1991, Volume: 52, Issue:3

Topics: 6-Ketoprostaglandin F1 alpha; Animals; Concanavalin A; Dinoprostone; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Kidney Glomerulus; Male; Pyridines; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase

1991